查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1961175

不孕症和懷孕快速檢測套組市場－全球產業規模、佔有率、趨勢、機會、預測：按類型、檢測類型、分銷管道、地區和競爭格局分類，2021-2031年

Fertility and Pregnancy Rapid Test Kits Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Type, By Test Type, By Distribution Channel, By Region & Competition, 2021-2031F
出版日期: | 出版商: TechSci Research | 英文 180 Pages | 商品交期: 2-3個工作天內

價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

簡介目錄

全球快速不孕症和妊娠檢測套組市場預計將從 2025 年的 21.9 億美元成長到 2031 年的 34.8 億美元，複合年成長率為 8.02%。

這些試劑盒作為診斷性免疫檢測盒，用於對生殖激素（特別是人類絨毛膜促性腺激素分泌和黃體激素）進行定性分析，旨在確認懷孕或識別排卵。該領域的成長受到婦科疾病發病率上升以及醫療模式轉向分散化策略的推動，後者需要便捷即時的診斷工具。此外，全球孕產婦年齡的成長趨勢也促使消費者傾向於居家檢測而非前往醫療機構，從而維持了市場需求並推動了生產商的財務成長。

市場概覽
預測期 2027-2031
市場規模：2025年 21.9億美元
市場規模：2031年 34.8億美元
複合年成長率：2026-2031年 8.02%
成長最快的細分市場 快速妊娠檢測套組
最大的市場 北美洲

然而，嚴格的法規結構阻礙了市場發展，導致遵循成本增加，產品核可時間延長。製造商面臨遵守複雜檢驗程序以確保設備準確性的挑戰，這往往會延緩關鍵地區的商業化。根據歐洲醫療技術協會（MedTech Europe）預測，到2025年，體外診斷試劑製造商預計用於維護和重新認證以滿足不斷變化的合規標準的支出將增加70%。這一沉重的財務負擔是創新者面臨的主要障礙，並限制了整體市場流動性。

市場促進因素

生育年齡延遲和人口老化的趨勢是推動市場擴張的主要動力。隨著女性優先考慮職涯發展並選擇延後生育，自然受孕的幾率降低，對精準排卵週期追蹤和早期懷孕檢測系統的需求也隨之增加。這種轉變導致人們更加依賴家用診斷試劑盒，以最大限度地提高在有限的排卵期內受孕的幾率。根據美國疾病管制與預防中心 (CDC) 於 2025 年 6 月發布的報告《美國初產婦平均年齡趨勢 (2016-2023)》，初產婦的平均年齡達到了創紀錄的 27.5 歲，凸顯了生育模式的改變。此外，大量針對意外懷孕的檢測也為相關業務帶來了可觀的收入。根據聯合國人口基金的說法，到 2025 年，約有 32% 的女性將經歷意外懷孕，這保證了對意外懷孕快速診斷的穩定需求。

同時，數位技術的引入和智慧型手機相容檢測功能的出現正在推動銷售成長。製造商們正致力於創新，用數位顯示器取代傳統的類比顯示螢幕，以提供更清晰的結果，並可透過藍牙連接追蹤應用程式。這種技術整合滿足了消費者對清晰度和個人化健康數據的需求，為品牌的高價策略提供了基礎。例如，根據 Church & Dwight 公司於 2025 年 10 月發布的 2025 年第三季財報，該公司淨銷售額成長了 5.0%，部分原因是其先進的個人保健產品組合表現強勁。這些發展鞏固了診斷設備在更廣泛的數位健康管理生態系統中的地位。

市場挑戰

嚴格的法規結構是全球快速不孕症和妊娠檢測套組市場發展的主要障礙。由於這些試劑盒被歸類為體外診斷醫療設備（IVD），製造商必須經過複雜的檢驗程序並提交嚴格的臨床數據以證明其安全性和準確性。這些日益嚴格的合規要求造成了巨大的進入門檻，尤其對於中小企業而言，因為這些要求延長了產品上市時間並增加了研發成本。因此，用於獲得監管核准的資金和資源往往會被挪用，直接阻礙創新檢測技術的商業性化應用。

這些監管壓力深刻影響企業在市場進入方面的策略選擇，導致企業傾向於避免或推遲在核准進度不確定的地區推出產品。由此產生的摩擦限制了新產品的供應，並縮小了關鍵市場的商機。根據歐洲醫療技術協會（MedTech Europe）預測，到2024年，由於當前複雜的監管環境，主要製造商選擇歐盟作為體外診斷新產品首發地的趨勢將下降40%。產品上市數量的下降表明，合規方面的挑戰正在直接阻礙市場流動性，並限制整個產業的成長。

市場趨勢

多激素交叉流式檢測技術的應用正在從根本上改變市場格局，它超越了簡單的黃體生成素檢測，提供全面的激素譜分析。製造商正在開發先進的試劑盒，能夠同時定量檢測孕酮代謝物（PdG）和雌激素，使用戶不僅可以預測排卵，還能確認排卵。這項發展滿足了消費者對詳細內分泌資訊的需求，幫助他們應對複雜的生育難題，並有效地將家庭診斷與臨床醫學聯繫起來。 2025年12月，Inito在一份題為「B輪資金籌措2,900萬美元，拓展不孕症治療以外的業務」的新聞稿中宣布，已獲得2,900萬美元融資，用於擴展其人工智慧驅動的抗體平台，該平台支援先進的多參數檢測功能。

同時，隨著相關人員將永續性發展置於優先地位，並努力減少一次性診斷試劑對環境的影響，向可生物分解和環保檢測設計轉型的趨勢正在加速。各公司正在擴大無塑膠機殼的研發，並採用來源可靠的材料，以滿足全球減少廢棄物的標準，並吸引具有環保意識的消費者。這項戰略調整涉及用可回收纖維取代傳統的聚合物組件，同時保持檢測的靈敏度和保存期限。例如，First Response品牌的母公司Church & Dwight Co., Inc.在其2025年4月發布的《2024年永續發展報告》中披露，該公司已將其全球包裝材料組合中原生塑膠的使用量減少了29%，這體現了其對材料創新的承諾。這也反映了整個產業為減少對生態系統的影響而採取的行動。

目錄

第1章概述

第2章：調查方法

第3章執行摘要

第4章：客戶心聲

第5章：全球不孕症與懷孕快速檢測套組市場展望

  • 市場規模及預測
    • 按金額
  • 市佔率及預測
    • 按類型（快速驗孕檢測套組、不孕症檢測套組）
    • 檢測類型（LH尿液檢查、FSH尿液檢查、hCG血液檢測、hCG尿液檢查）
    • 分銷通路（醫院通路、零售通路、線上通路）
    • 按地區
    • 按公司（2025 年）
  • 市場地圖

第6章：北美快速不孕症與妊娠檢測套組市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 北美洲：國別分析
    • 美國
    • 加拿大
    • 墨西哥

第7章：歐洲快速不孕症與妊娠檢測套組市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 歐洲：國別分析
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙

第8章：亞太地區不孕及妊娠快速檢測套組市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 亞太地區：國別分析
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳洲

第9章：中東及非洲快速不孕及妊娠檢測套組市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 中東與非洲：國別分析
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 南非

第10章：南美洲快速不孕不育與妊娠檢測套組市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 南美洲：國別分析
    • 巴西
    • 哥倫比亞
    • 阿根廷

第11章 市場動態

  • 促進因素
  • 任務

第12章 市場趨勢與發展

  • 併購
  • 產品發布
  • 近期趨勢

第13章：全球不孕症與妊娠快速檢測套組市場：SWOT分析

第14章：波特五力分析

  • 產業競爭
  • 新進入者的潛力
  • 供應商的議價能力
  • 顧客權力
  • 替代品的威脅

第15章 競爭格局

  • Swiss Precision Diagnostic GmbH
  • DCC Plc
  • The Procter & Gamble Company
  • Abbott Laboratories, Inc.
  • QuidelOrtho Corporation
  • bioMerieux SA
  • Church & Dwight Co., Inc.
  • Prestige Consumer Healthcare Inc.
  • Geratherm Medical AG
  • Biogenix Inc. Pvt. Ltd.

第16章 策略建議

第17章：關於研究公司及免責聲明

簡介目錄
Product Code: 24375

The Global Fertility and Pregnancy Rapid Test Kits Market is projected to expand from a valuation of USD 2.19 Billion in 2025 to USD 3.48 Billion by 2031, reflecting a CAGR of 8.02%. These kits function as diagnostic immunoassays intended for the qualitative analysis of reproductive hormones, particularly human chorionic gonadotropin and luteinizing hormone, to either confirm pregnancy or pinpoint ovulation windows. Growth in this sector is underpinned by an increasing incidence of gynecological conditions and a strategic transition toward decentralized healthcare models that demand accessible, immediate diagnostic tools. Additionally, the global trend of increasing maternal age encourages consumers to prefer home-based testing options over clinical appointments, thereby sustaining demand and driving financial growth for manufacturers.

Market Overview
Forecast Period2027-2031
Market Size 2025USD 2.19 Billion
Market Size 2031USD 3.48 Billion
CAGR 2026-20318.02%
Fastest Growing SegmentPregnancy Rapid Test Kits
Largest MarketNorth America

However, the market's progression is hindered by rigorous regulatory frameworks that escalate compliance expenses and extend product approval timelines. Manufacturers face the challenge of navigating intricate validation procedures to guarantee device precision, which often retards commercialization efforts in major regions. According to MedTech Europe, in 2025, in vitro diagnostic manufacturers indicated a forecasted 70% surge in expenditures related to maintenance and recertification to satisfy changing compliance norms. This significant financial obligation poses a major obstacle for innovators and limits the overall fluidity of the market.

Market Driver

The demographic trend toward delayed childbearing and advanced maternal age serves as a primary engine for market expansion. As women choose to postpone childbirth in favor of career advancement, the timeframe for natural conception decreases, creating a need for accurate ovulation tracking and early pregnancy detection systems. This shift fosters a greater dependence on home diagnostic kits to optimize the likelihood of conception during restricted fertile windows. According to the Centers for Disease Control and Prevention, June 2025, in the 'Trends in Mean Age of Mothers in the United States, 2016 to 2023' report, the average age of first-time mothers climbed to a historic peak of 27.5 years, highlighting this alteration in reproductive schedules. Furthermore, revenue streams are supported by the substantial volume of testing for unplanned pregnancies; according to the United Nations Population Fund, in 2025, roughly 32% of women reported experiencing an unintended pregnancy, guaranteeing steady demand for rapid diagnostics outside of planned conception.

Concurrently, the incorporation of digital and smartphone-enabled testing capabilities is propelling value sales. Manufacturers are innovating to supplant traditional analog lines with digital displays that provide clear results and Bluetooth connectivity to tracking applications. This technological integration satisfies consumer requests for clarity and personalized health data, enabling brands to justify premium pricing strategies. For instance, according to Church & Dwight Co., Inc., October 2025, in the 'Q3 2025 Results' report, the corporation declared a 5.0% rise in net sales, credited in part to the robust performance of its advanced personal care portfolio. These developments firmly situate diagnostic devices within the wider ecosystem of digital health management.

Market Challenge

The implementation of strict regulatory frameworks represents a major obstacle impeding the development of the Global Fertility and Pregnancy Rapid Test Kits Market. Because these kits are categorized as in vitro diagnostic (IVD) medical devices, manufacturers are compelled to undergo complicated validation procedures and present rigorous clinical data to verify safety and precision. These heightened compliance requirements establish significant entry barriers, especially for smaller companies, by prolonging time-to-market and increasing development expenditures. Consequently, the funds and resources necessary to obtain regulatory approval often redirect investment away from research and development, directly halting the commercial introduction of innovative testing technologies.

This regulatory pressure profoundly influences strategic choices concerning market entry, leading manufacturers to bypass or postpone product launches in territories characterized by uncertain approval schedules. The consequent friction limits the accessibility of new products and curtails revenue possibilities in critical markets. According to MedTech Europe, in 2024, the inclination to select the European Union as the initial launch location for new in vitro diagnostic products fell by 40% among major manufacturers due to the intricacies of the prevailing regulatory landscape. This reduction in product introductions illustrates how compliance challenges directly obstruct market fluidity and restrict the sector's overall growth.

Market Trends

The adoption of multi-hormone lateral flow assays is fundamentally transforming the market by expanding beyond simple luteinizing hormone detection to provide comprehensive hormonal mapping. Manufacturers are engineering advanced kits capable of simultaneously quantifying progesterone metabolites (PdG) and estrogen, which allows users to confirm ovulation rather than simply predicting it. This evolution meets the consumer desire for detailed endocrine information to address complex fertility challenges, effectively connecting home diagnostics with clinical healthcare. According to Inito, December 2025, in the 'Inito raises $29M to expand beyond fertility' press release, the firm obtained $29 million in Series B financing to expand its AI-driven antibody platform, which supports this sophisticated multi-parameter testing functionality.

At the same time, the shift toward biodegradable and eco-friendly test designs is accelerating as stakeholders emphasize sustainability to lessen the environmental burden of single-use diagnostics. Companies are increasingly developing plastic-free housings and using responsibly sourced materials to comply with global waste reduction standards, thereby attracting environmentally aware consumers. This strategic adjustment entails substituting conventional polymer parts with recyclable fibers while maintaining assay sensitivity and shelf-life. Illustrating this dedication to material innovation, according to Church & Dwight Co., Inc., April 2025, in the '2024 Sustainability Report', the parent entity of the First Response brand realized a 29% decrease in virgin plastic usage across its global packaging portfolio, mirroring the industry-wide movement toward reduced ecological impact.

Key Market Players

  • Swiss Precision Diagnostic GmbH
  • DCC Plc
  • The Procter & Gamble Company
  • Abbott Laboratories, Inc.
  • QuidelOrtho Corporation
  • bioMerieux SA
  • Church & Dwight Co., Inc.
  • Prestige Consumer Healthcare Inc.
  • Geratherm Medical AG
  • Biogenix Inc. Pvt. Ltd.

Report Scope

In this report, the Global Fertility and Pregnancy Rapid Test Kits Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Fertility and Pregnancy Rapid Test Kits Market, By Type

  • Pregnancy Rapid Test Kits
  • Fertility Rapid Test Kits

Fertility and Pregnancy Rapid Test Kits Market, By Test Type

  • LH Urine
  • FSH Urine
  • hCG Blood
  • hCG Urine

Fertility and Pregnancy Rapid Test Kits Market, By Distribution Channel

  • Hospital Channel
  • Retail Channel
  • Online Channel

Fertility and Pregnancy Rapid Test Kits Market, By Region

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • United Kingdom
    • Italy
    • Germany
    • Spain
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Fertility and Pregnancy Rapid Test Kits Market.

Available Customizations:

Global Fertility and Pregnancy Rapid Test Kits Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Fertility and Pregnancy Rapid Test Kits Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Type (Pregnancy Rapid Test Kits, Fertility Rapid Test Kits)
    • 5.2.2. By Test Type (LH Urine, FSH Urine, hCG Blood, hCG Urine)
    • 5.2.3. By Distribution Channel (Hospital Channel, Retail Channel, Online Channel)
    • 5.2.4. By Region
    • 5.2.5. By Company (2025)
  • 5.3. Market Map

6. North America Fertility and Pregnancy Rapid Test Kits Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Type
    • 6.2.2. By Test Type
    • 6.2.3. By Distribution Channel
    • 6.2.4. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Fertility and Pregnancy Rapid Test Kits Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Type
        • 6.3.1.2.2. By Test Type
        • 6.3.1.2.3. By Distribution Channel
    • 6.3.2. Canada Fertility and Pregnancy Rapid Test Kits Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Type
        • 6.3.2.2.2. By Test Type
        • 6.3.2.2.3. By Distribution Channel
    • 6.3.3. Mexico Fertility and Pregnancy Rapid Test Kits Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Type
        • 6.3.3.2.2. By Test Type
        • 6.3.3.2.3. By Distribution Channel

7. Europe Fertility and Pregnancy Rapid Test Kits Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Type
    • 7.2.2. By Test Type
    • 7.2.3. By Distribution Channel
    • 7.2.4. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. Germany Fertility and Pregnancy Rapid Test Kits Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Type
        • 7.3.1.2.2. By Test Type
        • 7.3.1.2.3. By Distribution Channel
    • 7.3.2. France Fertility and Pregnancy Rapid Test Kits Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Type
        • 7.3.2.2.2. By Test Type
        • 7.3.2.2.3. By Distribution Channel
    • 7.3.3. United Kingdom Fertility and Pregnancy Rapid Test Kits Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Type
        • 7.3.3.2.2. By Test Type
        • 7.3.3.2.3. By Distribution Channel
    • 7.3.4. Italy Fertility and Pregnancy Rapid Test Kits Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Type
        • 7.3.4.2.2. By Test Type
        • 7.3.4.2.3. By Distribution Channel
    • 7.3.5. Spain Fertility and Pregnancy Rapid Test Kits Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Type
        • 7.3.5.2.2. By Test Type
        • 7.3.5.2.3. By Distribution Channel

8. Asia Pacific Fertility and Pregnancy Rapid Test Kits Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Type
    • 8.2.2. By Test Type
    • 8.2.3. By Distribution Channel
    • 8.2.4. By Country
  • 8.3. Asia Pacific: Country Analysis
    • 8.3.1. China Fertility and Pregnancy Rapid Test Kits Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Type
        • 8.3.1.2.2. By Test Type
        • 8.3.1.2.3. By Distribution Channel
    • 8.3.2. India Fertility and Pregnancy Rapid Test Kits Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Type
        • 8.3.2.2.2. By Test Type
        • 8.3.2.2.3. By Distribution Channel
    • 8.3.3. Japan Fertility and Pregnancy Rapid Test Kits Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Type
        • 8.3.3.2.2. By Test Type
        • 8.3.3.2.3. By Distribution Channel
    • 8.3.4. South Korea Fertility and Pregnancy Rapid Test Kits Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Type
        • 8.3.4.2.2. By Test Type
        • 8.3.4.2.3. By Distribution Channel
    • 8.3.5. Australia Fertility and Pregnancy Rapid Test Kits Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Type
        • 8.3.5.2.2. By Test Type
        • 8.3.5.2.3. By Distribution Channel

9. Middle East & Africa Fertility and Pregnancy Rapid Test Kits Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Type
    • 9.2.2. By Test Type
    • 9.2.3. By Distribution Channel
    • 9.2.4. By Country
  • 9.3. Middle East & Africa: Country Analysis
    • 9.3.1. Saudi Arabia Fertility and Pregnancy Rapid Test Kits Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Type
        • 9.3.1.2.2. By Test Type
        • 9.3.1.2.3. By Distribution Channel
    • 9.3.2. UAE Fertility and Pregnancy Rapid Test Kits Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Type
        • 9.3.2.2.2. By Test Type
        • 9.3.2.2.3. By Distribution Channel
    • 9.3.3. South Africa Fertility and Pregnancy Rapid Test Kits Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Type
        • 9.3.3.2.2. By Test Type
        • 9.3.3.2.3. By Distribution Channel

10. South America Fertility and Pregnancy Rapid Test Kits Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Type
    • 10.2.2. By Test Type
    • 10.2.3. By Distribution Channel
    • 10.2.4. By Country
  • 10.3. South America: Country Analysis
    • 10.3.1. Brazil Fertility and Pregnancy Rapid Test Kits Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Type
        • 10.3.1.2.2. By Test Type
        • 10.3.1.2.3. By Distribution Channel
    • 10.3.2. Colombia Fertility and Pregnancy Rapid Test Kits Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Type
        • 10.3.2.2.2. By Test Type
        • 10.3.2.2.3. By Distribution Channel
    • 10.3.3. Argentina Fertility and Pregnancy Rapid Test Kits Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Type
        • 10.3.3.2.2. By Test Type
        • 10.3.3.2.3. By Distribution Channel

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Merger & Acquisition (If Any)
  • 12.2. Product Launches (If Any)
  • 12.3. Recent Developments

13. Global Fertility and Pregnancy Rapid Test Kits Market: SWOT Analysis

14. Porter's Five Forces Analysis

  • 14.1. Competition in the Industry
  • 14.2. Potential of New Entrants
  • 14.3. Power of Suppliers
  • 14.4. Power of Customers
  • 14.5. Threat of Substitute Products

15. Competitive Landscape

  • 15.1. Swiss Precision Diagnostic GmbH
    • 15.1.1. Business Overview
    • 15.1.2. Products & Services
    • 15.1.3. Recent Developments
    • 15.1.4. Key Personnel
    • 15.1.5. SWOT Analysis
  • 15.2. DCC Plc
  • 15.3. The Procter & Gamble Company
  • 15.4. Abbott Laboratories, Inc.
  • 15.5. QuidelOrtho Corporation
  • 15.6. bioMerieux SA
  • 15.7. Church & Dwight Co., Inc.
  • 15.8. Prestige Consumer Healthcare Inc.
  • 15.9. Geratherm Medical AG
  • 15.10. Biogenix Inc. Pvt. Ltd.

16. Strategic Recommendations

17. About Us & Disclaimer